Insider Transactions in Q4 2020 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 26
2020
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
61,000
+32.74%
|
-
|
|
Oct 26
2020
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
178,300
+43.9%
|
-
|
|
Oct 26
2020
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
81,000
+22.66%
|
-
|
|
Oct 26
2020
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
61,000
+27.13%
|
-
|
|
Oct 26
2020
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
61,000
+36.55%
|
-
|
|
Oct 26
2020
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
81,000
+42.41%
|
-
|
|
Oct 22
2020
|
Todd Bazemore |
BUY
Open market or private purchase
|
Indirect |
40
+48.78%
|
$280
$7.6 P/Share
|